HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Y Asano Selected Research

digital ulcers

2/2016Fli1 deficiency contributes to the downregulation of endothelial protein C receptor in systemic sclerosis: a possible role in prothrombotic conditions.
2/2012Effects of bosentan on nondigital ulcers in patients with systemic sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Y Asano Research Topics

Disease

23Systemic Scleroderma (Systemic Sclerosis)
02/2021 - 06/2001
10Infections
01/2005 - 04/2000
9Fibrosis (Cirrhosis)
07/2020 - 03/2006
8Inflammation (Inflammations)
04/2019 - 11/2001
7Localized Scleroderma (Morphea)
07/2020 - 06/2001
7Psoriasis (Pustulosis Palmaris et Plantaris)
03/2016 - 03/2011
5Pulmonary Fibrosis (Fibrosing Alveolitis)
09/2015 - 06/2001
5Mixed Connective Tissue Disease (MCTD)
04/2005 - 09/2001
4Neoplasms (Cancer)
08/2021 - 02/2001
4Interstitial Lung Diseases (Interstitial Lung Disease)
02/2018 - 11/2002
4Cicatrix (Scar)
02/2018 - 11/2000
4Necrosis
03/2016 - 01/2000
4Hypersensitivity (Allergy)
09/2008 - 11/2000
4Graft vs Host Disease (Graft-Versus-Host Disease)
03/2004 - 12/2000
3Sclerosis
02/2021 - 03/2012
3Osteoporosis
12/2020 - 03/2001
3Breast Neoplasms (Breast Cancer)
01/2019 - 06/2016
3Pulmonary Arterial Hypertension
09/2015 - 02/2012
3Atopic Dermatitis (Atopic Eczema)
01/2013 - 03/2012
3Diffuse Scleroderma (Progressive Systemic Sclerosis)
03/2012 - 06/2005
3Chronic Kidney Failure (Chronic Renal Failure)
01/2006 - 07/2000
3Exanthema (Rash)
10/2001 - 07/2001
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
11/2018 - 09/2012
2Telangiectasis (Telangiectasia)
02/2018 - 10/2009
2Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
01/2018 - 01/2013
2Muscle Cramp (Cramp)
12/2016 - 12/2016
2Rheumatoid Arthritis
03/2016 - 09/2005
2Skin Diseases (Skin Disease)
03/2016 - 01/2013
2digital ulcers
02/2016 - 02/2012
2Insulin Resistance
03/2013 - 04/2012
2Leukemia
11/2012 - 01/2005
2Ulcer
02/2012 - 11/2000
2Renal Insufficiency (Renal Failure)
04/2011 - 05/2006
2Fever (Fevers)
04/2011 - 09/2000
2Hypokalemia
11/2010 - 01/2006
2Hypertension (High Blood Pressure)
11/2010 - 03/2001
2Hypocalcemia
11/2010 - 01/2006
2Hemorrhage
07/2010 - 05/2001
2Dermatomyositis (Dermatopolymyositis)
01/2007 - 11/2002
2Polymyositis
01/2007 - 05/2002
2Heart Failure
01/2006 - 12/2001
2Eosinophilic Fasciitis
08/2004 - 02/2003
2Virus Diseases (Viral Diseases)
12/2003 - 09/2000
2Glomerulonephritis
06/2002 - 07/2000
2Bone Resorption
06/2002 - 03/2001
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2001 - 03/2001
2Inborn Genetic Diseases (Disease, Hereditary)
09/2001 - 03/2000
2Edema (Dropsy)
06/2001 - 01/2001

Drug/Important Bio-Agent (IBA)

8Proteins (Proteins, Gene)FDA Link
04/2012 - 01/2001
6AntibodiesIBA
04/2011 - 06/2001
4Interleukin-12 (IL 12)IBA
08/2021 - 09/2000
4Biomarkers (Surrogate Marker)IBA
02/2021 - 03/2000
4Cyclosporine (Ciclosporin)FDA LinkGeneric
07/2013 - 12/2000
4EnzymesIBA
01/2013 - 02/2003
4ImmunosorbentsIBA
01/2013 - 02/2003
4DNA (Deoxyribonucleic Acid)IBA
08/2001 - 09/2000
3CreatinineIBA
11/2010 - 12/2000
3Immunoglobulin M (IgM)IBA
07/2005 - 01/2001
3Rheumatoid FactorIBA
07/2005 - 01/2003
3RNA (Ribonucleic Acid)IBA
05/2002 - 06/2001
3Messenger RNA (mRNA)IBA
02/2001 - 08/2000
2Rituximab (Mabthera)FDA Link
01/2017 - 01/2016
2Prednisolone (Predate)FDA LinkGeneric
01/2017 - 06/2006
2Immunosuppressive Agents (Immunosuppressants)IBA
01/2017 - 06/2006
2Lipocalin-2IBA
09/2015 - 04/2012
2AdipokinesIBA
09/2015 - 03/2013
2C-Reactive ProteinIBA
06/2013 - 01/2003
2CollagenIBA
11/2012 - 02/2006
2CytokinesIBA
04/2012 - 03/2012
2Indicators and Reagents (Reagents)IBA
04/2012 - 06/2001
2AdiponectinIBA
03/2012 - 03/2011
2Retinaldehyde (Retinal)IBA
04/2011 - 10/2000
2ReninIBA
11/2010 - 07/2001
2AldosteroneIBA
11/2010 - 07/2001
2Carbon MonoxideIBA
10/2009 - 03/2006
2Peptides (Polypeptides)IBA
09/2008 - 07/2006
2Intravenous Immunoglobulins (IVIG)FDA Link
05/2007 - 06/2005
2AutoantibodiesIBA
01/2007 - 08/2000
2Matrix Metalloproteinase 13IBA
07/2006 - 03/2006
2Immunoglobulin A (IgA)IBA
06/2006 - 10/2004
2SteroidsIBA
06/2006 - 07/2000
2agalactosyl IGGIBA
04/2005 - 10/2004
2AntigensIBA
01/2005 - 10/2002
2Immunoglobulin G (IgG)IBA
10/2004 - 11/2000
2Tissue Inhibitor of Metalloproteinase-1IBA
08/2004 - 07/2002
2Tissue Inhibitor of MetalloproteinasesIBA
08/2004 - 07/2002
2CD40 Ligand (CD40L)IBA
02/2003 - 02/2003
2Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA
11/2002 - 06/2001
2OsteoprotegerinIBA
06/2002 - 03/2001
2GlucocorticoidsIBA
06/2002 - 03/2001
2RibonucleoproteinsIBA
09/2001 - 06/2001
2Atrial Natriuretic Factor (ANF)IBA
09/2001 - 02/2000
2Pharmaceutical PreparationsIBA
06/2001 - 04/2000

Therapy/Procedure

9Therapeutics
01/2017 - 07/2000
4Transplantation
07/2001 - 07/2000
4Liver Transplantation
06/2001 - 09/2000
3Bone Marrow Transplantation (Transplantation, Bone Marrow)
07/2001 - 12/2000
2Drug Therapy (Chemotherapy)
07/2020 - 01/2019
2Plasmapheresis
06/2006 - 07/2000
2Renal Dialysis (Hemodialysis)
06/2003 - 09/2001